• 1
    Schroeder KW, Tremaine WJ & Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317: 16259.
  • 2
    Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S & Turnberg LAI. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988; 29: 66974.
  • 3
    Rachmilewicz D. Coated mesalazine (5 aminosalicylic acid) versus sulfasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 1989; 298: 826.
  • 4
    Sninsky CA, Cort DH & Shanahan F, et al. Oral mesalamine (Asacol) for mildly to moderaltely active ulcerative colitis: a multicenter study. Ann Intern Med 1991; 115: 3505.
  • 5
    Hanauer SB, Schwarz J & Robinson M, et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Am J Gastroenterol 1993; 88: 118897.
  • 6
    Sutherland LR. GR & Shaffer EA. Sulfasalazine revisited: a meta-analysis of five aminsalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 5409.
  • 7
    Campieri M, Lanfranchi GA & Bazzocchi G, et al. Treatment of ulcerative colitis with high dose 5 aminosalicylic acid enemas. Lancet 1981; ii: 2701.
  • 8
    Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ & May RJ. 5-aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Am J Gastroenterol 1986; 81: 4128.
  • 9
    Sutherland LR, Martin F & Greer S, et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 18948.
  • 10
    Campieri M, Gionchetti P & Belluzzi A, et al. Optimun dosage of 5-aminosalicylic acid as rectal enemas in patients with ulcerative colitis. Gut 1991; 32: 92931.
  • 11
    Pullman RD, Ganesh S & Mani V, et al. Comparison of bismuth citrate and 5-aminosalicyilic acid enemas in distal ulcerative colitis. A controlled trial. Gut 1993; 34: 6769.
  • 12
    Hanauer SB. Dose-ranging study of mesalamine (Pentasa) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. Inflamm Bowel Dis 1998; 4: 7983.
  • 13
    Marshall JK & Irvine EJ. Rectal aminosalicyilate therapy for distal ulcerative colitis. A meta-analysis. Aliment Pharmacol Ther 1995; 9: 293300.
  • 14
    Biddle W, Greenberger NJ, Swan JT, McPhee MS & Miner PB. 5-aminosalycilic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988; 95: 10759.
  • 15
    Marteau P, Crand J, Foucault M & Rambaud J-C. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study. Gut 1998; 42: 1959.
  • 16
    D’Albasio G, Paoluzzi P & Campieri M, et al. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. Am J Gastroenterol 1998; 93: 799803.
  • 17
    De Franchis R, Vecchi M, Carpinelli L, Meucci G & Torgano G. Comparison of the efficacy and safety of sulphasalaziene and mesalazines in the maintenance treatment of ulcerative colitis: a meta-analysis. Eur J Gastroenterol Hepatol 1993; 5: 50510.
  • 18
    Prakash A & Markham A. Oral delayed-release mesalazine. A review of its use in ulcerative colitis and Crohn’s disease. Drugs 1999; 57: 383408.
  • 19
    Gionchetti P, Rizzello P & Venturi A, et al. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Dis Col Rectum 1998; 41: 937.
  • 20
    Safdi M, De Micco M & Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol 1997; 92: 18677.
  • 21
    D’Albasio G, Pacini F & Camarri E, et al. Combined therapy with 5-Aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis; a randomized double-blind study. Am J Gastroenterol 1997; 92: 11437.
  • 22
    Farrell RJ & Falchuk KR. Double therapy for IBD better than single therapy? The issue is not how but how much. Inflamm Bowel Dis 1999; 5: 6870.
  • 23
    Miglioli M, Bianchi Porro G & Brunetti G, et al. Oral delayed-release mesalazine in the treatment of mild ulcerative colitis: a dose-ranging study. Eur J Gastroenterol Hepatol 1990; 2: 22934.